{
    "nctId": "NCT00826397",
    "briefTitle": "Acupuncture for Aromatase Inhibitor Induced Joint Pain",
    "officialTitle": "Pilot Study on the Effect of Acupuncture on Joint Pain Induced by Aromatase Inhibitors in Breast Cancer Patients",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "Change in Joint Pain",
    "eligibilityCriteria": "INCLUSION CRITERIA:\n\n* Age\\>45 years\n* Postmenopausal status defined as cessation of menses for \\>1 year or follicle- stimulating hormone (FSH)\\>20 mIU/mL\n* History of stage I or II, hormone receptor-positive breast cancer\n* Currently taking a third-generation aromatase inhibitor (anastrazole, letrozole or exemestane)\n* Ongoing musculoskeletal pain in one or more joints (baseline BPI worst pain score \\> 3 points on a scale of 0 to 10)\n* English-speaking\n* Signed informed consent\n\nEXCLUSION CRITERIA:\n\n* Previous treatment with acupuncture\n* Inflammatory, metabolic or neuropathic arthropathies\n* Bone fracture or surgery of the afflicted extremity during the past six months\n* Current narcotic use, corticosteroid therapy or cortisone injections\n* Severe concomitant illnesses or metastatic disease\n* Severe coagulopathy or bleeding disorder\n* Dermatological disease within the acupuncture area",
    "sex": "FEMALE",
    "minimumAge": "45 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}